DVM360 (July 16) – A novel combination of 2 immunotherapy drugs is being evaluated via a multisite clinical study to see if it is effective against cancer in canine patients with solid tumors. Dr. Tim Fan at the University of Illinois Urbana-Champaign is one of seven veterinary oncology researchers involved in the multisite, open-label evaluation of the product called “Checkmate K9” created by a company called Vetigenics.
https://www.dvm360.com/view/first-dog-receives-combination-immunotherapy-in-new-cancer-trial